CHARLENE HAGEN: Open Payments
NPI 1306154463 · FARMINGTON, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 22 payments from 10 companies in 2025. Trend: 2023 $456 · 2024 $591 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| Lilly USA, LLC | 3 | $59 |
| ABBVIE INC. | 2 | $58 |
| PFIZER INC. | 3 | $51 |
| Novo Nordisk Inc | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
| Amgen Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: JARDIANCE, MOUNJARO, BREZTRI, Ozempic, QULIPTA, NURTEC ODT, XIFAXAN, Veozah.
Industry payments across NM — which companies pay providers there.
